European drugmakers say they are ‘losing ground’ to US and Chinese rivals
- Chinese: 82 events in the last 90 days
- Previous: earlier the same day · BMW CEO sees risk of cheap Chinese cars in Europe but opposes tariffs
What happened
Some of continent’s biggest pharma firms write to national leaders calling for action to safeguard their futures Some of Europe’s biggest pharmaceutical companies have said the continent is “losing ground” to rivals including the US and China in developing new drugs and attracting investment. The chairs of nine companies, including Britain’s AstraZeneca, GSK and Denmark’s Novo Nordisk, wrote to Andy Burnham and the…
Summary assembled by rule from the sources below